Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit.

导出 OA

翻译打印收藏纠错

第一作者： Neal,Bhutiani

第一单位： Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

作者： Neal,Bhutiani ^[1] ; Travis E,Grotz ^[2] ; Seth J,Concors ^[1] ; Michael G,White ^[3] ; Beth A,Helmink ^[1] ; Kanwal P,Raghav ^[4] ; Melissa W,Taggart ^[5] ; Karen A,Beaty ^[1] ; Richard E,Royal ^[6] ; Michael J,Overman ^[4] ; Aurelio,Matamoros ^[7] ; Christopher P,Scally ^[1] ; Safia,Rafeeq ^[1] ; Paul F,Mansfield ^[1] ; Keith F,Fournier ^[8]

作者单位： Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[1] Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA. ^[2] Department of Colon and Rectal Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[3] Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[4] Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[5] Division of Surgical Oncology, Department of Surgery, Maine Medical Center, Portland, ME, USA. ^[6] Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ^[7] Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. kffourni@mdanderson.org. ^[8]

关键词 Appendiceal cancer Cytoreduction HIPEC Recurrence